Sakai et al.
comparison of the 13C NMR data with those reported.17
(2R*,3S*)-(()-2: mp 72-73 °C (lit.17 mp 74-76 °C). IR (KBr)
3240 (N-H), 2818 (O-H) cm-1. 1H NMR (CDCl3) δ 7.34-7.24
(m, 5H), 3.92 (dd, 1H, J ) 5.5, 11.7 Hz), 3.74 (dd, 1H, J ) 6.6,
11.7 Hz), 2.52 (dd, 1H, J ) 5.5, 6.6 Hz), 1.85 (br s, 2H), 1.54
(s, 3H). 13C NMR (CDCl3) δ 144.5, 128.5, 127.1, 125.9, 61.3,
44.0, 42.3, 20.1.
was monitored by TLC. The lipase was removed by filtration
through Celite pad quickly, and the filtrate was concentrated
under reduced pressure. The products were separated by
column chromatography (EtOAc), and the enantiomeric puri-
ties of both 2 and 2a were determined by capillary GC, using
a CP-cyclodextrin-â-2,3,6-M-19 column (Chrompack, Φ 0.25
mm × 25 m, oven temperature 130 °C): retention time ) 56.9
min for (2S,3R)-2, 59.1 min for (2R,3S)-2, 61.3 min for (2R,3S)-
2a, and 63.8 min for (2S,3R)-2a.
tert-Butyl 3-Methyl-2H-azirine-2-carboxylate [(()-1b]
was prepared from tert-butyl acetoacetate (5b) in a similar way
to the reported procedure.6 â-Keto ester 5b (3.16 g, 20 mmol)
was added to a solution of NH2OH‚HCl (1.53 g, 22 mmol) and
NaHCO3 (1.85 g, 22 mmol) in aqueous MeOH. After the
mixture was stirred at room temperature for 1 h, a usual
workup gave an oily crude product 6b, which was dissolved
in CH2Cl2 (10 mL). A solution of TsCl (3.81 g, 20 mmol) and
pyridine (1.58 g, 20 mmol) in CH2Cl2 (10 mL) was added, and
the mixture was stirred for 3 h. Usual workup and purification
by column chromatography (EtOAc/hexane ) 4/1) gave 7b
(5.06 g, 77%) as a mixture of syn/anti isomers (32/68 by NMR).
The stereochemistry of syn and anti isomers was not assigned
spectroscopically.6 The major isomer was isolated by recrys-
tallization from Et2O for analysis. Oxime tosylate 7b: major,
white solid, mp 93-95 °C. IR (KBr) 1720 (CdO), 1355, 1157
(SdO) cm-1. 1H NMR (CDCl3) δ 7.84 (d, 2H, J ) 8.2 Hz), 7.32
(d, J ) 8.2 Hz), 3.16 (s, 2H), 2.43 (s, 3H), 2.03 (s, 3H), 1.39 (s,
9H). 13C NMR (CDCl3) δ 166.7, 162.0, 144.8, 132.4, 129.4,
128.5, 82.0, 41.8, 27.7, 21.5, 15.8. Minor: 1H NMR (CDCl3) δ
7.84 (d, 2H, J ) 8.2 Hz), 7.32 (d, J ) 8.2 Hz), 3.34 (s, 2H),
2.43 (s, 3H), 2.00 (s, 3H), 1.43 (s, 9H).
To a solution of tosylate 7b (2.94 g, 8.98 mmol) in CH2Cl2
(20 mL) was added Et3N (1.00 g, 9.87 mmol) dropwise with
ice cooling. After the mixture was stirred at room temperature
for 6.5 h, the usual workup gave an oily crude product,
which was purified by bulb-to-bulb distillation (100-110 °C
(4 mmHg); lit.6 110 °C (0.5 mmHg)) to give 0.92 g (66%) of
(()-1b as a colorless oil. Azirine ester 1b: IR (film): 1801 (Cd
N), 1732 (CdO) cm-1. 1H NMR (CDCl3) δ 2.50 (s, 3H), 2.34 (s,
1H), 1.45 (s, 9H). 13C NMR (CDCl3) δ 171.1, 159.3, 81.4, 29.7,
28.1, 12.6.
(2S,3R)-2a: colorless oil. IR (film) 3295 (N-H), 1731 (Cd
1
O), 1603 (N-H) cm-1. H NMR (CDCl3) δ 7.33-7.24 (m, 5H),
4.26 (d, 2H, J ) 6.6 Hz), 2.48 (t, 1H, J ) 6.6 Hz), 2.11 (s, 3H),
1.55 (s, 3H). 13C NMR (CDCl3) δ 170.9, 144.3, 128.5, 127.1,
125.9, 64.5, 41.6, 40.7, 20.9, 20.3. [R]29D +23.8 (c 0.33, CHCl3),
70% ee. Anal. Calcd for C12H15NO2: C, 70.22; H, 7.37; N, 6.82.
Found: C, 70.08; H, 7.36; N, 7.08.
(2R,3S)-2: colorless oil. [R]21D -31.3 (c 0.75, CHCl3), 87% ee.
Butanoate of 3-Methyl-3-phenyl-2-aziridinemethanol
(2S,3R)-2b (Table 1, entry 10): colorless oil. IR (film) 3242
(N-H), 1735 (CdO), 1602 (N-H) cm-1 1H NMR (CDCl3) δ
.
7.34-7.22 (m, 5H), 4.32 (dd, 1H, J ) 6.6, 11.8 Hz), 4.24 (dd,
1H, J ) 6.6, 11.8 Hz), 3.47 (br s, 1H), 2.50 (t, 1H, J ) 6.6 Hz),
2.36 (t, 2H, J ) 7.4 Hz), 1.78-1.60 (m, 2H), 1.56 (s, 3H), 0.93
(t, 3H, J ) 7.4 Hz). 13C NMR (CDCl3) δ 173.6, 144.4, 128.5,
127.1, 126.0, 64.3, 41.7, 40.8, 36.2, 20.4, 18.5, 13.7. Anal. Calcd
for C14H19NO2: C, 72.07; H, 8.21; N, 6.00. Found: C, 72.32;
H, 8.26; N, 5.65. GC analysis (oven temperature 150 °C,
retention time of the butanoate: 69.2 min for (2R,3S) and 71.3
min for (2S,3R). [R]21 +31.8 (c 0.75, CHCl3), 90% ee.
D
General Procedure for the Lipase-Catalyzed Resolu-
tion of (()-3. To a mixture of (()-3 (50 mg, 0.30 mmol) and
lipase PS or PS-C II in acetone (5 mL) was added vinyl acetate
at the temperature indicated in Table 2. The resulting suspen-
sion was vigorously stirred, and the reaction progress was
monitored by TLC. After workup in a usual manner, the
percent ee value of (2R,3R)-3a was determined by capillary
GC using a CP-cyclodextrin-â-2,3,6-M-19 column (Chrompack,
Φ 0.25 mm × 25 m, oven temperature 130 °C): retention time
) 47.6 min for (2S,3S)-3a and 49.4 min for (2R,3R)-3a. The
enantiomeric purity of (2S,3S)-3 was determined by HPLC
using a Chiralpak AD-H column (hexane/i-PrOH ) 9/1, flow
rate 1.0 mL/min, detection 254 nm), 8.3 min for (2S,3S)-3 and
9.7 min for (2R,3R)-3).
tert-Butyl (2R*,3R*)-3-Methyl-3-phenylaziridine-2-car-
boxylate [(()-9]. A solution of azirine ester 1b (1.29 g, 8.31
mmol) in THF (30 mL) was cooled to -80 °C, and a THF
solution of PhMgBr [magnesium turning (0.81 g, 33.25 mmol),
bromobenzene (5.22 g, 33.25 mmol), and 50 mL of THF] was
added dropwise through a dropping funnel. After the mixture
was stirred at -80 °C for 1 h, the reaction was quenched with
H2O (2 mL) at -80 °C. A usual workup gave crude products
(isomeric ratio of 76/24 by 1H NMR), which were separated
by column chromatography (hexane/EtOAc ) 4/1) to give the
major (0.93 g, 48%) and minor products (0.32 g, 17%).
Major product: (()-9, colorless oil, Rf 0.30 (hexane/EtOAc
(2S,3S)-3: white solid, mp 107-108 °C. [R]26D +89.8 (c 1.10,
CHCl3), 99% ee.
(2R,3R)-3a: colorless oil. IR (film) 3305 (N-H), 1732 (Cd
1
O), 1604 (N-H) cm-1. H NMR (CDCl3) δ 7.41-7.23 (m, 5H),
3.86 (dd, 1H, J ) 5.4, 11.8 Hz), 3.49 (dd, 1H, J ) 7.4, 11.8
Hz), 2.49 (dd, 1H, J ) 5.4, 7.4 Hz), 2.03 (s, 3H), 1.64 (s, 3H).
13C NMR (CDCl3) δ 170.9, 140.1, 128.3, 127.5, 127.1, 65.4, 42.5,
41.0, 28.0, 20.9. Anal. Calcd for C12H15NO2: C, 70.22; H, 7.37;
N, 6.82. Found: C, 70.06; H, 7.51; N, 6.82. [R]26D -31.5 (c 0.98,
CHCl3), 94% ee.
) 2/1). IR (film) 3240 (N-H), 1716 (CdO), 1610 (N-H) cm-1
.
1H NMR (CDCl3) δ 7.32-7.23 (m, 5H), 2.67 (s, 1H), 1.70 (br s,
1H), 1.56 (s, 3H), 1.19 (s, 9H). 13C NMR (CDCl3) δ 167.7, 139.5,
127.6, 126.8, 126.7, 80.9, 45.5, 43.2, 27.2, 27.0. Anal. Calcd
for C14H19NO2: C, 72.07; H, 8.21; N, 6.00. Found: C, 72.35;
H, 8.12; N, 6.11.
(2S,3R)-3-Methyl-3-phenyl-2-aziridinemethanol [(2S,3R)-
2] from 3-Phenyl-2H-azirine-2-methanol [(S)-10]. To a
solution of (S)-103a (150 mg, 1.0 mmol) in THF (15 mL) was
added MeMgBr [4.6 mL (4.0 mmol, 0.87 M in THF)] dropwise
at room temperature and the mixture was stirred at room
temperature for 3 h. A usual workup and purification by
column chromatography (EtOAc) gave a 93:7 (1H NMR)
inseparable diastereomeric mixture of (2S,3R)-2 and (2S,3S)-3
(126 mg, 71% yield). Thus, the mixture (93 mg, 0.57 mmol)
was dissolved in THF (3 mL), and a THF (2 mL) solution of
imidazole (82 mg, 1.2 mmol) and a THF (3 mL) solution of
TBS-Cl (181 mg, 1.2 mmol) were added subsequently. After
being stirred at room temperature for 4.5 h, the mixture was
treated in a usual manner to give products, which were
purified by column chromatography (hexane/EtOAc ) 5/1) to
afford a mixture of TBS ethers (2S,3R)-11 and (2S,3S)-12 (132
mg, 84% yield) as oily products. The mixture was separated
by preparative HPLC on a YMC-Pack SIL column (Φ 6 mm ×
Minor product: (()-8,4b Rf 0.60 (hexane/EtOAc ) 2/1).
3-Methyl-3-phenyl-2-aziridinemethanol [(()-3] was pre-
pared in 72% yield and >99% de (1H NMR) by a similar
procedure to that for (()-2. (()-3: mp 102-103 °C. IR (KBr)
3251 (N-H), 2821 (O-H), 1603 (N-H) cm-1. 1H NMR (CDCl3)
δ 7.42-7.23 (m, 5H), 3.38 (dd, 1H, J ) 5.6, 11.7 Hz), 3.11 (1H,
dd, J ) 7.0, 11.7 Hz), 2.47 (dd, J ) 5.6, 7.0 Hz), 1.64 (s, 3H),
1.47 (br s, 2H). 13C NMR (CDCl3) δ 140.4, 128.2, 127.4, 126.9,
62.5, 44.6, 43.0, 28.0. The 13C NMR spectral data are consistent
with those reported.17
General Procedure for the Lipase-Catalyzed Resolu-
tion of (()-2. To a mixture of (()-2 (50 mg, 0.30 mmol) and
lipase PS or PS-C II in an organic solvent (5 mL) was added
vinyl acetate at the temperature indicated in Table 1. The
suspension was vigorously stirred, and the reaction progress
1374 J. Org. Chem., Vol. 70, No. 4, 2005